Genomic medicine is evolving rapidly, driven by breakthroughs in therapeutics, advances in diagnosis, and expanding access to genetic services. The ACMG Fall 2026 Seminar Series is designed for medical geneticists, laboratory geneticists, genetic counselors, trainees, and the broader genetics team, following that arc across three sessions. The series brings evolving trends in genomic medicine into a new forum between the 2026 and 2027 Annual Clinical Genetics Meetings, keeping the field’s most timely conversations going year-round, including:
• October 7, 2026: Session 1: Novel and Emerging Therapeutics
• November 4, 2026: Session 2: Smarter Diagnosis
• December 2, 2026: Session 3: Cancer, Equity, and Global Access
Each session is held virtually on the first Wednesday of the month, October through December 2026, 11:00 AM to 12:30 PM ET, running approximately 90 minutes across two ~45-minute presentations followed by discussion.
This series delivers practical, current updates across the frontiers of genomic medicine, from gene therapy, CRISPR, and expanding skeletal dysplasia treatments to clinical use of the human pangenome, genomic reanalysis, integrated cancer risk assessment, and genomic testing in low- and middle-income settings. Together, the three sessions aim to equip the genetics team to translate emerging therapeutics, diagnostics, and equity-focused approaches into real-world patient care.